The few existing studies have suggested that SMYD4 acts as a tumor suppressor in breast cancer by locally inhibiting platelet growth factor receptor [59], while miR-1307-3p can promote tumor cell proliferation by targeting SMYD4 transcripts [18]. Here, SMYD4 is linked to breast carcinoma.